RMTI News & Events

Rockwell Medical announced that the Company has renewed and extended its product purchase agreement with aQua Dialysis a leading independent provider of in-center hemodialysis and home dialysis services in Texas. The Agreement, which includes supply and purchasing commitments, will be in effect for two years with options to renew for two additional one-year periods. Under the Agreement, Rockwell Medical will continue to supply aQua Dialysis with the Company's liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialysis related products.

Rockwell Medical announced that the company entered into a three-year product purchase agreement with Heritage Dialysis, a Michigan-based family-owned company comprised of dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes. The Agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options to renew for three additional one-year periods. Under the Agreement, Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including the company's premium grade, single-use 720g bicarbonate cartridge, PureCart; liquid acetic acid-based RenalPure; liquid bicarbonate SteriLyte; as well as other dialysis related ancillary products.

Reports Q1 revenue $17.3M vs. $18.9M last year. "Our financial and operational performance in the first quarter 2026 builds on the positive trajectory we have established across our key financial metrics, which we expect to continue throughout the remainder of the year," said Mark Strobeck, CEO. "By streamlining our operations, we are on track to generate meaningful cost savings that we believe will support sustained profitability. Our 2026 guidance is centered around strengthening revenue, expanding gross margin, and generating positive Adjusted EBITDA and cash flow."